Skip to main content
Log in

Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Estrogen protects against developing premature coronary artery disease.However, the mechanism of protective effects of estrogen still remainspoorly understood. One mechanism by which estrogen can have protectiveeffects apppears to be through modulation of plasma lipoproteins. We showedthat the mouse can be used as animal model to study estrogen-mediatedsynthesis and secretion of lipoproteins since, unlike the rat, the mousedoes not up-regulate LDL receptors (Srivastava et al. [4]). Since inbredstrains of mice differ in their genetic background and show differingresponsiveness to dietary lipids, we examined how various inbred strains ofmice respond to estradiol administration, and whether some mouse strainsshow responses similar to rats. 17b-estradiol was administered to male micefrom 15 different inbred strains, and the changes in plasma levels oflipids, apoB, apoAI, and apoE were examined. Total cholesterol decreased inall but one strain, apoAI levels decreased in all but 3 strains while apoBlevels and apoB/apoAI ratios increased in all but 2 strains, suggesting thatin contrast to rats, the apoB-containing lipoproteins increased relative toHDL in all strains of mice examined. Basal and estradiol-induced changes intotal cholesterol were significantly correlated with changes in apoAI, butnot apoB, reflecting the predominance of HDL over other lipoproteins inmouse plasma. The effects of estrogen on plasma apoE levels varied amongvarious inbred strains of mice tested. Plasma apoE levels increased in sevenstrains treated with estrogen, and remained unchanged in the rest. Toexamine whether changes of plasma apoproteins are associated with thechanges in the respective hepatic mRNA levels, apoAI, B and E mRNA werequantified by RNase protection assay. Hepatic apoE mRNA did not showcorrelation with either basal or post treatment plasma apoE levels in any ofthe strains. Similarly, most of the mouse strains did not show correlationof plasma apoAI and apoB levels with the corresponding hepatic mRNA levels.These results suggest that estrogen regulates plasma lipoproteinconcentrations primarily by posttranscriptional mechansims, and there werestrain-related differences in the estrogen-mediated regulation oflipoprotein metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kannel WB, Hjiortland MC, McNamara PM, Gordon T: Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med 85: 447–452, 1976

    Google Scholar 

  2. Kushwaha RP, Lewis DS, Carey KD, McGill HC Jr: Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon. Metabolism. 11: 23–31, 1991

    Google Scholar 

  3. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shiverly CA, Adams MR: Estrogen and progesterone therapy reduces low-density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88: 1995–2002, 1991

    Google Scholar 

  4. Srivastava RAK, Baumann D, Schonfeld G: In vivoregulation of low density lipoprotein receptors by estrogen differs at the posttranscriptional levels in rat and mouse. Eur J Biochem 216: 527–538, 1993

    Google Scholar 

  5. Srivastava RAK, Kitchens RT, Schonfeld G: Regulation of the apolipoprotein AIV gene expression by estrogen differs in rat and mouse. Eur J Biochem 222: 507–514, 1994

    Google Scholar 

  6. Srivastava RAK, Jiao S, Tang J, Pfleger B, Kitchens RT, Schonfeld G: In vivoregulation of low density lipoprotein receptor and apolipoprotein B gene expression by dietary fat and cholesterol in inbred strains of mice. Biochim Biophys Acta 1086: 2943, 1991

    Google Scholar 

  7. Yang CY, Chan SH, Gianturco SH, Bradely WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M, Lee FS, Gu ZW, Gotto AM Jr, Chan L: Sequence, structure, receptor binding domains and internal repeats of human apolipoprotein B-100. Nature 323: 738–742, 1986

    Google Scholar 

  8. Glickman RM, Rogers M, Glickman JM: Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci USA 83: 5296–5300, 1986

    Google Scholar 

  9. Lock DR, Hockenberry D, Cunningham J, Hahm KS, Kantor O, Schonfeld G: Apolipoprotein B subspecies in chylomicrons isolated from a patient with chyluria. Am J Med 75: 360–364, 1983

    Google Scholar 

  10. Kane JP, Sata T, Hamilton RL, Havel RJ: Apoprotein composition of very low density lipoproteins of human serum. J Clin Invest 56: 1622–1634, 1975

    Google Scholar 

  11. Elovson J, Huang YO, Baker N, Kannan R: Apolipoprotein B is structurally and metabolically heterogeneous in the rat. Proc Natl Acad Sci USA 78: 157–161, 1981

    Google Scholar 

  12. Pullinger CR, North JD, Teng B-B, Rifici VA, Ronhild de Brito AE, Scott J: The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30: 1065–1077, 1989

    Google Scholar 

  13. Moberly JB, Cole TG, Alpers DH, Schonfeld G: Oleic acid stimulation of apolipoprotein B secretion from HepG2 and Caco-2 cells occurs post-transcriptionally. Biochim Biophys Acta 1042: 70–80, 1990

    Google Scholar 

  14. Dixon JL, Furukawa S, Ginsberg HN: Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 266: 5080–5086, 1991

    Google Scholar 

  15. Srivastava RAK, Tang J, Baumann D, Schonfeld G: Hormonal and nutritional stimuli modulate apolipoprotein B mRNA editing in mouse liver. Biochem. Biophys Res Commun 188: 135–141, 1992

    Google Scholar 

  16. Shimano H., Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa T, Yazaki Y: Proc Natl Acad Sci USA, 89: 1750–1754, 1992

    Google Scholar 

  17. Zhang SH, Reddick RL, Pierdrahita JA, Maeda N: Science 258: 468–471, 1992

    Google Scholar 

  18. Srivastava RAK, Srivastava N, Schonfeld G: Expression of low density lipoprotein receptor, apolipoprotein AI, apolipoprotein AII and apolipoprotein AIV in various rat organs utilizing an efficient method for RNA isolation. Biochem Intern 27: 85–95, 1992

    Google Scholar 

  19. Lin RC: Quantification of apolipoproteins in rat serum and in culture red rat hepatocytes by enzyme-linked immunosorbent assay. Anal Biochem 154: 316–326, 1986

    Google Scholar 

  20. Srivastava RAK, Tang J, Krul ES, Pfleger B, Kitchens RT, Schonfeld G: Dietary fatty acids and dietary cholesterol differ in their effects on the in vivoregulation of apolipoprotein AI and apolipoprotein AII gene expression in inbred strains of mice. Biochim Biophys Acta 1125: 251–261, 1992

    Google Scholar 

  21. Srivastava RAK, Pfleger B, Schonfeld G: Expression of LDL-receptor, apolipoprotein B, apolipoprotein AI and apolipoprotein AIV mRNA in various mouse organs as determined by a novel solution hybridization assay. Biochim Biophys Acta 1090: 95–101, 1991

    Google Scholar 

  22. Srivastava RAK, Schonfeld G: Using riboprobes for Northern blot analysis. Bio/Techniques 11: 584–587, 1991

    Google Scholar 

  23. Srivastava RAK: Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and posttranscriptional mechanisms. Mol Cell Biochem 155: 153–162, 1996

    Google Scholar 

  24. Linton MF, Babaev VR, Gleaves LA, Atkinson JB, Fazio S: Increased atherosclerosis in C57BL/6 mice transplanted with apolipoprotein E deficient marrow. Circulation pplement 94: 2313, 1996

    Google Scholar 

  25. Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE: J Clin Invest 96: 2170–2179, 1995

    Google Scholar 

  26. Zhang W-Y, Gaynor PM, Kruth HS: Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 271: 28641–28646, 1996

    Google Scholar 

  27. Staels B, Auwerx J, Chan L, Tol AV, Rosseneu M, Verhoeven G: Influence of development, estrogens, and food intake on apolipoprotein AI, AII and E mRNA in rat river and intestine. J Lipid Res 30: 1137–1145, 1989

    Google Scholar 

  28. Meinstein I, Turner FC, Soler-Argilaga C, Heimberg M: Effect of ethinyl estradiol on serum lipoprotein lipids in male and female rats. Biochim Biophys Acta 530: 394–401, 1978

    Google Scholar 

  29. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI: The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Endocrinol Metab 57: 262–277, 1983

    Google Scholar 

  30. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM: Differential effects of estrogen on low density lipoprotein subclasses in healthy postmenopausal women. Metabolism 42: 1153–1158, 1993

    Google Scholar 

  31. Granfone A, Campos H, McNamara HR, Schaefer MM, Lamon-Fava S, Ordovas JM, Schaefer EJ: Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism 41: 1193–1198, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srivastava, R.A.K., Krul, E.S., Lin, R.C. et al. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms. Mol Cell Biochem 173, 161–168 (1997). https://doi.org/10.1023/A:1006896131186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006896131186

Navigation